Caprock Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Caprock Group’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,887	Closed	-$285K	–	1206
2025 Q3	$285K	Buy	+4,887	New	+$279K	0.01%	958
2025 Q1	$218K	Buy	+3,087	New	+$208K	0.01%	982
2023 Q2	–	Sell	-2,065	Closed	-$201K	–	665
2023 Q1	$201K	Buy	2,065 +118	+6%	+$12.2K	0.02%	597
2022 Q4	$201K	Buy	+1,947	New	+$183K	0.02%	509

Other funds holding BMRN

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return